170749 ⎘
Post-translational modifications [PTMs] in chemical analysis of biological material addition of carbohydrates, e.g. glycosylation, glycation
ANTIBODY MOLECULES TO APRIL AND USES THEREOF
#2COMPOSITIONS AND METHODS FOR ANALYZING SOLUBLE PROTEINS
#3METHODS OF DIAGNOSING OR TREATING LYME DISEASE
#4ENDOGLYCOSIDASE-ASSISTED PEPTIDE MAPPING
#5CELL-FREE CLOSTRIDIAL NEUROTOXIN ASSAYS
#6ANALYTICAL METHOD FOR GLYCOGONJUGATES USING A CAPILLARY-BASED IMMUNOASSAY SYSTEM
#7Method for Preparing Specimen for Analysis and Method for Analyzing Same
#8METHODS FOR ANALYZING TRANSFERRIN GLYCOFORMS
#9METHODS FOR IDENTIFYING OR QUANTITATING PEPTIDES
#10GLYCOPROTEIN ASSESSMENT
#11MEANS AND METHODS FOR HIGH-THROUGHPUT GLYCOPROFILING OF PROTEINS
#12GLYCOFORM SPECIFIC NANOBODIES AND METHODS OF USE
#13METHOD FOR MEASURING GLYCOSYLATED SURFACE ANTIGEN PROTEIN OF HBV
#14AFUCOSYLATION OF HLA-SPECIFIC IGG1 AS A POTENTIAL PREDICTOR OF ANTIBODY PATHOGENICITY IN KIDNEY TRANSPLANTATION
#15METHOD FOR EXAMINING BLOOD SAMPLE
#16HIGH AFFINITY ANTIBODIES SPECIFICALLY BINDING TO a-1,6-CORE-FUCOSYLATED ALPHA-FETOPROTEIN
#17GLYCAN STRUCTURES OF HAPTOGLOBIN AS A BIOMARKER OF HEPATOCELLULAR CARCINOMA
#18METHODS FOR MANAGEMENT OF PROSTATE CANCER
#19METHODS TO CHARACTERIZING A FRAGMENT CRYSTALLIZABLE DOMAIN OF A BISPECIFIC ANTIBODY
#20FC-GAMMA RECEPTOR II BINDING AND GLYCAN CONTENT
#21METHODS OF DETECTING AND TREATING IMMUNOTHERAPY-RESISTANT CANCER
#22COMPOSITIONS AND METHODS RELATED TO PROTEIN LABELING
#23METHODS OF MULTIPLEXED ANALYTE CHARACTERIZATION
#24GLYCAN AGE PREDICTION MODEL
#25ASSAYS FOR ALPHA-DYSTROGLYCAN GLYCOSYLATION AND METHODS FOR USING SAME
#26STANDARD FOR GLYCOPROFILING OF PROTEINS
#27TARGET-BASED METHOD FOR HIGH-THROUGHPUT AND SUBCLASS SPECIFIC IgG GLYCAN PROFILING IN HUMAN PLASMA
#28METHOD AND DEVICE FOR DETECTING BIOMOLECULE
#29METHODS OF DIAGNOSING OR TREATING LYME DISEASE
#30Sialylated Glycoproteins
#31Method for detecting binding to an ADP-ribosyl group or a polymer thereof and a kit for performing said method
#32L-FUCOSE AND ANTI-ANDROGEN RECEPTOR THERAPY FOR TREATMENT OF CANCER
#33HUMANIZED ANTI-SIALYL-TN GLYCAN ANTIBODIES AND USES THEREOF
#34Sialylated Glycoproteins
#35GLYCOFORM SPECIFIC NANOBODIES AND METHODS OF USE
#36METHODS OF QUANTIFYING ANTI-CD40 ANTIBODIES
#37Sialylated Glycoproteins
#38Biomarkers for diagnosing non-alcoholic steatohepatitis (NASH) or hepatocellular carcinoma (HCC)
#39AUTOMATED REAL-TIME, ON-LINE N-GLYCOSYLATION MONITORING METHODS AND SYSTEMS THEREOF
#40USE OF THE EMM ANTIGEN AS A BIOMARKER OF INHERITED GPI DEFICIENCIES
#41Flow Cytometry Platform for the Detection of Glycosylated Proteins in a Clinical Sample
#42DEGLYCOSYLATION METHODS FOR ELECTROPHORESIS OF GLYCOSYLATED PROTEINS
#43METHOD AND APPARATUS FOR EVALUATING DEGREE OF GLYCATION OF PROTEIN
#44SINGLE CELL GLYCAN PROFILING
#45POLYOL BIOMARKERS FOR CONGENITAL DISORDERS OF GLYCOSYLATION
#46Method for maximizing coronavirus killing activity of high-density lipoproteins, and pharmaceutical composition for preventing or treating COVID-19
#47INTEGRATED PROTEOMIC BIOMARKERS FOR THE DETECTION OF AGGRESSIVE PROSTATE CANCER
#48CIRCULATING TOTAL-NT-PROBNP (GLYCOSYLATED AND UNGLYCOSYLATED NT-PROBNP) AND ITS RATIO WITH NT-PROBNP (UNGLYCOSYLATED NT-PROBNP) IN THE ASSESSMENT OF ATRIAL FIBRILLATION
#49ANALYTICAL METHOD FOR GLYCOGONJUGATES USING A CAPILLARY-BASED IMMUNOASSAY SYSTEM
#50METHODS RELATED TO BIOLOGICS
#51CELLULAR MATERIAL DETECTION PROBES
#52ENGINEERED PROBES FOR SIALOGLYCAN BINDING
#53METHOD AND DEVICE FOR ANALYZING SIALIC-ACID-CONTAINING GLYCAN
#54AUTOIMMUNE HEPATITIS BIOMARKERS
#55MEASUREMENT OF AFUCOSYLATED IGG FC GLYCANS AND RELATED COVID-19 TREATMENT METHODS
#56Isobaric Multiplex Reagents for Carbonyl Containing Compound High-Throughput Quantitative Analysis
#57METHODS FOR THE QUANTIFICATION OF GLYCOPROTEINS
#58Detection and Treatment of Pregnancy Complications Comprising Determining Sialyl Lewis Antigens and Administering hCG
#59METHODS, COMPOSITIONS, AND KITS FOR HIGH-THROUGHPUT RELEASE, LABELING, AND ANALYSIS OF O-GLYCANS PRESENT ON A GLYCOCONJUGATE
#60GLYCATED PROTEIN ASSAY REAGENT CONTAINING STABILIZER OF PROTEASE THAT INCREASES OXIDATION-REDUCTION POTENTIAL OF FERROCYANIDE, METHOD FOR ASSAYING GLYCATED PROTEIN, METHOD FOR PRESERVING GLYCATED PROTEIN ASSAY REAGENT, AND METHOD FOR STABILIZING GLYCATED PROTEIN ASSAY REAGENT
#61ANTIBODIES SPECIFIC TO GLYCOSYLATED PD-L1 AND METHODS OF USE THEREOF
#62Methods for the rapid preparation of labeled glycosylamines and for the analysis of glycosylated biomolecules producing the same
#63OPTIMIZED FRAGMENTATION FOR QUANTITATIVE ANALYSIS OF FUCOSYLATED N-GLYCOPROTEINS BY LC-MS-MRM
#64METHODS TO IMPROVE DETECTION OF GLYCOSYLAMINES
#65Biomarkers for diagnosing non-alcoholic steatohepatitis (NASH) or hepatocellular carcinoma (HCC)
#66Labelled compounds and methods for mass spectrometry-based quantification
#67Glycated CD59 peptides, their preparation, and uses thereof
#68Antibodies specific to glycosylated PD-L1 and methods of use thereof
#69Dye-based liquid reagent volume indicator for use in analyte detection assays
#70Calibrators and controls for the determination of percent glycated hemoglobin in a patient's liquid test sample
#71Materials and Methods for Glycan Profiling
#72Method for Predicting Prognosis of Ischemic Disease
#73Method for detecting target substance, reagent for detecting target substance
#74ANTIBODIES SPECIFIC FOR GLYCOSYLATED APOJ AND USES THEREOF
#75GLYCAN OXONIUM ION PROFILING OF GLYCOSYLATED PROTEINS
#76SUGAR CHAIN SPECIFIC TO PROSTATE CANCER, AND TEST METHOD USING SAME
#77Sialylated Glycoproteins
#78MICROSAMPLING DETECTION IN DIABETES
#79Deglycosylation methods for electrophoresis of glycosylated proteins
#80GLYCAN ANALYSIS OF PROTEINS AND CELLS
#81Glycopeptide analyzer
#82BIOMARKER FOR DETECTING CANCER
#83Sialylated Glycoproteins
#84AFFINITY CHROMATOGRAPHY-COUPLED NATIVE MASS SPECTROMETRY FOR ANTIBODY ANALYSIS
#85Sialylated Glycoproteins
#86Method and system for analyzing N-linked sugar chains of glycoprotein
#87APOE MODIFICATIONS AND USES THEREOF
#88Methods for detecting and for treating pancreatic cancer
#89ApoCIII and the Treatment and Diagnosis of Diabetes
#90BIOMARKERS TO DETECT AND CHARACTERISE CANCER
#91Detection and treatment of pregnancy complications comprising determining sialyl Lewis antigens and administering hCG
#92Methods for liquid chromatography calibration for rapid labeled N-glycans
#93System for monitoring post-translational modification of protein using bio-sensor with gap and manufacturing method for bio-sensor
#94Method for preparing analytical sample, analysis method, and kit for preparing analytical sample
#95Cleavable probes for isotope targeted glycoproteomics and methods of using the same
#96SIALYLATED GLYCOPROTEINS
#97Diagnostic method of liver cancer using α-fetoprotein derived glycopeptides by mass spectrometry
#98Targeted protein characterization by mass spectrometry
#99Separable cassette for measuring glycated hemoglobin
#100Carbonyl containing compound high-throughput quantitative analysis using isobaric multiplex reagents
#101GLYCOSYLATED METABOLITES
#102Labelled compounds and methods for mass spectrometry-based quantification
#103Use of glycan as biomarkers for autoimmune diseases
#104SATURATION BINDING RATIOMETRIC ASSAY
#105Methods and kits for the diagnosis and risk stratification of patients with ischemia
#106METHOD FOR ANALYZING SIALYL SUGAR CHAIN
#107Method of diagnosing arthritis or other joint degrading disease
#108Cleavable probes for isotope targeted glycoproteomics and methods of using the same
#109METHODS OF EVALUATING AND MAKING BIOLOGICS
#110METHODS OF GLYCOPROTEIN ANALYSIS
#111METHODS RELATED TO ADALIMUMAB
#112ASSAYS FOR B-TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION
#113Surface, anchored FC-bait antibody display system
#114Methods related to biologics
#115Determination of glycosylation signature
#116Method for verifying the primary structure of protein
#117ApoCIII and the Treatment and Diagnosis of Diabetes
#118Method for estimating pathological tissue diagnosis result (Gleason score) of prostate cancer
#119Detection and treatment of pregnancy complications comprising determining sialyl Lewis antigens and administering hCG
#120METHODS FOR IMPROVING DIABETES MANAGEMENT
#121Sialylated Glycoproteins
#122Methods for enriching glycopeptides for global analysis of glycoproteins
#123Systems and methods for the detection of HbA1c
#124Cleavage of Fucose in N-Glycans
#125Glycated CD59 peptides, their preparation, and uses thereof
#126Methods for molecular classification of fatty liver by high-throughput protein post-translational modifications
#127Method for measuring glycated protein using interdigitated electrode
#128Method for monitoring post-translational modification of protein
#129Measurement method and measurement device
#130Method for detecting protein-specific glycosylation
#131Methods for the rapid preparation of labeled glycosylamines and for the analysis of glycosylated biomolecules producing the same
#132Method of preparing sample for analysis and analysis method
#133METHODS AND KITS FOR CANCER ANTIGEN AND HEPARAN SULFATE IMAGING
#134METHOD FOR SCREENING DIABETIC NEPHROPATHY IN A SUBJECT
#135Surface anchored light chain bait antibody display system
#136Antibodies, pharmaceutical compositions and uses thereof
#137Antibodies specific to glycosylated PD-L1 and methods of use thereof
#138METHOD OF MAPPING GLYCANS OF GLYCOPROTEINS
#139Method of preparing sample for analysis and analysis method
#140Method of detecting the level of a glycan
#141SURFACE, ANCHORED FC-BAIT ANTIBODY DISPLAY SYSTEM
#142Sialylated fetuin-A as a marker of immunotherapy efficacy
#143Monoclonal antibody reacting with glycopeptide, and use thereof
#144Methods for liquid chromatography calibration for rapid labeled N-glycans
#145Methods to Diagnose and Treat Multiple Sclerosis via Detection of Altered Protein Components of Serum
#146Lung cancer differential marker
#147Multi-dimensional chromatographic methods for separating N-glycans
#148Surrogates of post-translationally modified proteins and uses thereof
#149Carbohydrate-binding protein
#150In vitro process for the quantification of carboxymethyl and carboxyethyl level of albumin in a sample
#151Agents and methods for determining colorectal cancer status
#152ApoIII and the treatment and diagnosis of diabetes
#153Assays for B-type natriuretic peptide analogues resistant to prolyl-specific dipeptidyl degradation
#154Sandwich assay using labeled lectin and kit therefor
#155A-fucosylation detection in antibodies
#156Methods and reagents for the assessment of gestational diabetes
#157Lectins and applications for the detection of pathological state markers
#158METHOD AND MEANS FOR THE NON-INVASIVE DIAGNOSIS OF TYPE II DIABETES MELLITUS
#159IMMUNOCHROMATOGRAPHIC ANALYSIS DEVICE, IMMUNOCHROMATOGRAPHIC ANALYSIS METHOD, AND IMMUNOCHROMATOGRAPHIC ANALYSIS KIT
#160Use of glycan as biomarkers for autoimmune diseases
#161Antibodies, pharmaceutical compositions and uses thereof
#162SURROGATES OF POST-TRANSLATIONALLY MODIFIED PROTEINS AND USES THEREOF
#163GLYCOMIC PATTERNS FOR THE DETECTION OF DISEASE
#164Multi-dimensional chromatographic methods for separating N-glycans
#165Surface, anchored Fc-bait antibody display system
#166Compositions and methods for analysis of protein sequences and post-translational modifications
#167Insulin receptor substrate 1 (IRS1) protein SRM/MRM assay
#168Method for determining site having N-linked sugar chain added thereto or proportion of said addition
#169Methods and devices for detection and measurement of analytes
#170MATERIALS AND METHODS FOR ANALYSING GLYCATION
#171Glycans as functional cancer targets and antibodies thereto
#172Chemiluminescent Protein Chip, Method and Kit for Detecting Seroglycoid Fucosylation Index
#173Cleavable probes for isotope targeted glycoproteomics and methods of using the same
#174Method for diagnosing cancer through detection of deglycosylation of glycoprotein
#175METHODS AND COMPOSITIONS RELATING TO NEURODEGENERATIVE DISEASES
#176SIALYLATED GLYCOPROTEINS
#177Method for the analysis of N-glycans attached to immunoglobulin G from human blood plasma and its use
#178METHOD FOR QUANTIFYING GLYCATED HEMOGLOBIN
#179CATION EXCHANGER FOR LIQUID CHROMATOGRAPHY, PROCESS FOR PRODUCING SAME, AND USE THEREOF
#180MOLECULAR LABELING METHODS
#181Methods of cell culture
#182Monoclonal antibody recognizing sialylated sugar chains
#183ApoIII and the Treatment and Diagnosis of Diabetes
#184MAMMALIAN PROTEIN CO-RECOGNITION BY BROADLY NEUTRALIZING ANTIBODIES AS MODIFIED IMMUNOGENS FOR RE-ELICITATION
#185IMPROVED METHOD OF MAPPING GLYCANS OF GLYCOPROTEINS
#186BREAST-CANCER DETERMINATION METHOD
#187Diagnosis of Alzheimer Disease, Cognitive Decline and Dementia
#188Method for determining glycosylation and terminal modification of samples during protein purification process
#189Deglycosylation Reagents and Methods
#190Glycoform detection method and glycoform detection device
#191GLYCATED CD59 PEPTIDES, THEIR PREPARATION, AND USES THEREOF
#192Method for suppressing nonspecific signals from contaminants in an immunoassay using surface plasmon-field enhanced fluorescence spectroscopy (SPFS)
#193DETECTION AND TREATMENT OF PREGNANCY COMPLICATIONS
#194Methods and reagents for glycoproteomics
#195Isotopically labeled glycans and methods for producing the same
#196Methods related to denosumab
#197Methods of detecting conjugation site-specific and hidden epitope/antigen
#198METHODS OF EVALUATING AND MAKING BIOLOGICS
#199Bioinformatics platform for high-throughput identification and quantification of N—glycopeptide
#200DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
#201Method for in vivo production of deglycosylated recombinant proteins used as substrate for downstream protein glycoremodeling
#202Identification and quantification of intact glycopeptides in complex samples
#203METHODS RELATED TO ADALIMUMAB
#204METHODS RELATED TO PANITUMUMAB
#205Surface anchored light chain bait antibody display system
#206METHOD FOR DETECTING CANCER, AND ANTIBODY CAPABLE OF RECOGNIZING PANCREATIC RIBONUCLEASE 1
#207METHODS RELATED TO BEVACIZUMAB
#208High-Throughput Method For Sialic Acid Quantitation
#209Methods and devices for detection and measurement of analytes
#210Method for determining the glycosylation of an antibody
#211Raman spectroscopy for detection of glycated analytes
#212Aptamers for detection and measurement of analytes
#213Targeting c-Rel O-GlcNAcylation and uses thereof
#214Methods and compositions for detecting and modulating O-glycosylation
#215Methods for assessing modified LDL immune complexes in subjects having or at risk of coronary artery disease
#216Methods for improving diabetes management
#217Lung cancer differential marker
#218High mannose glycans
#219Bladder cancer tumor marker, antibody and use thereof
#220Multi-dimensional chromatographic methods for separating N-glycans
#221Insulin receptor substrate 1 (IRS1) protein SRM/MRM assay
#222BIOMARKERS FOR ASSESSING SIALIC ACID DEFICIENCIES
#223Cancer diagnosis marker using the aberrant glycosylation of a protein
#224Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
#225HEPATOCELLULAR CARCINOMA MARKER
#226Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
#227Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
#228A-FUCOSYLATION DETECTION IN ANTIBODIES
#229Diagnosis of restenosis in patients undergoing percutaneous coronary intervention
#230Method for pre-treating sample containing glycated hemoglobin
#231ApoIII and the treatment and diagnosis of diabetes
#232Glucuronidated Acetaminophen as a Marker of Hepatic Disorders
#233Methods for assessing modified LDL immune complexes in subjects having or at risk of coronary artery disease
#234High-Throughput Method for Quantifying Sialylation of Glycoproteins
#235Methods for identifying compounds for the treatment of type 1 diabetes
#236Early detection of diabetes
#237Methods and compositions for detections and modulating O-glycosylation
#238Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
#239Multi-dimensional chromatographic methods for separating N-glycans
#240Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction
#241COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE AND MYOCARDIAL INFARCTION WITH DIPEPTIDYL PEPTIDASE INHIBITORS OR B TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION
#242Methods for identifying compounds for the treatment of type 1 diabetes
#243Methods for Identifying Compounds for the Treatment of Type 1 Diabetes
#244Glycomic patterns for the detection of disease
#245COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE AND MYOCARDIAL INFARCTION WITH DIPEPTIDYL PEPTIDASE INHIBITORS OR B TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION
#246Pharmacological profiling of drugs with cell-based assays
#247Methods and compositions for measuring natriuretic peptides and uses thereof